In this Issue:
Sofaranib for advanced differentiated thyroid cancer
131I-MIBG therapy for malignant paraganglioma and phaeochromocytoma
Cardiovascular risk factors in children with CAD
Falsely undetectable TSH in euthyroid patients
Hydrocortisone replacement therapy with a physiological cortisol exposure
GO and discrepancies in TBII assays and TSI bioassay
Parathyroidectomy and cardiovascular outcomes in secondary hyperparathyroidism
Differentiating between Cushing’s and pseudo-Cushings’s
MicroRNA profile of poorly differentiated thyroid carcinomas
TSH screening for AFTN: Not an appropriate test?
Please login below to download this issue (PDF)